CAS No.: 31477-60-8
Ormeloxifene Catalog No. CSN20291
Synonyms: ORM;Centchroman;67/20CDRI
Ormeloxifene, an estrogen receptor regulator, suppresses prostate tumor growth and metastatic phenotypes via inhibition of oncogenic β-catenin signaling and EMT progression
| 规格 | 价格 | 促销价格 | 库存 | 数量 |
|---|
400-920-2911
sales@csnpharm.cn
tech@csnpharm.cn
纯度 & 质量文件
批次:
靶点选择性
生物活性
- 描述
- 参考文献
- [1] Hafeez BB, Ganju A, et al. Ormeloxifene suppresses prostate tumor growth and metastatic phenotypes via inhibition of oncogenic β-catenin signaling and EMT progression. Mol Cancer Ther. 2017 Jun 14. pii: molcanther.0157.2017.
- [2] Khan S, Ebeling MC, et al. Ormeloxifene suppresses desmoplasia and enhances sensitivity of gemcitabine in pancreatic cancer. Cancer Res. 2015 Jun 1;75(11):2292-304.
实验方案
- 计算器
- 储存液制备
技术信息
| CAS号 | 31477-60-8 | 储存条件 |
|
|
| 分子式 | C30H35NO3 | 运输 | 蓝冰 | |
| 分子量 | 457.60 | 别名 | ORM;Centchroman;67/20CDRI;CDRI-67/20;CDRI 6/20;CDRI-6720 |
